EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Enzyme-responsive targeted nanomedicines: a novel strategy for cancer therapy

Mingtang Zeng, Zhongzhen Yang, Liuxuan Yang, Xueyan Wang, Yao Wang, Tao Chen, Xi Yin, Fengbo Wu

Journal of Materials Chemistry B · 2026 · 14 (12) · 3661-3692

DOI: 10.1039/d6tb00076b ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Materials Chemistry B, 2026. Verfasst von Mingtang Zeng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, West China Hospital, Sichuan University, Chengdu 610041, China. fbwu2013@163.com. Hauptthemen laut MEDLINE: Nanomedicine, Neoplasms, Antineoplastic Agents, Enzymes. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 244 Literaturangaben. Gefördert von: National Key Clinical Specialty Discipline Construction Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enzyme-responsive targeted nanomedicines have emerged as a promising approach for precision cancer therapy, capitalizing on the unique biochemical features of the tumor microenvironment (TME) to achieve localized and controlled drug release.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanomedicineNeoplasmsAntineoplastic AgentsEnzymesHumansTumor MicroenvironmentAnimalsDrug Carriers

Substanzen

Antineoplastic AgentsDrug CarriersEnzymes

Autor:innen und Institutionen

  • Department of Pharmacy, West China Hospital, Sichuan University, Chengdu 610041, China. fbwu2013@163.com.
  • Innovation Institute for Integration of Medicine and Engineering, Particle Radiotherapy Innovation Laboratory (PRIL), Med-X Center for Mamufacturing, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, Chi…
  • Department of Pharmacy, Yibin Hospital Affiliated to Children's Hospital of Chongqing Medical University, No. 108, Shangmao road, Xuzhou district, Yibin, Sichuan, P.R. China.

Förderung

  • National Key Clinical Specialty Discipline Construction Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Zeng, M., Yang, Z., Yang, L., Wang, X., Wang, Y., Chen, T., Yin, X., & Wu, F. (2026). Enzyme-responsive targeted nanomedicines: a novel strategy for cancer therapy. Journal of Materials Chemistry B, 14(12), 3661-3692. https://doi.org/10.1039/d6tb00076b

Vancouver

Zeng M, Yang Z, Yang L, Wang X, Wang Y, Chen T, et al. Enzyme-responsive targeted nanomedicines: a novel strategy for cancer therapy. Journal of Materials Chemistry B. 2026;14(12):3661-3692. doi:10.1039/d6tb00076b

BibTeX
@article{Zeng2026,
  author = {Zeng, Mingtang and Yang, Zhongzhen and Yang, Liuxuan and Wang, Xueyan and Wang, Yao and Chen, Tao and Yin, Xi and Wu, Fengbo},
  title = {Enzyme-responsive targeted nanomedicines: a novel strategy for cancer therapy},
  journal = {Journal of Materials Chemistry B},
  year = {2026},
  volume = {14},
  number = {12},
  pages = {3661--3692},
  doi = {10.1039/d6tb00076b}
}
Kostenlos starten →